Selected article for: "biological function study and biomedical research"

Author: Xie, Frank Y.; Woodle, Martin C.; Lu, Patrick Y.
Title: Harnessing in vivo siRNA delivery for drug discovery and therapeutic development
  • Cord-id: dkvoorxt
  • Document date: 2006_2_13
  • ID: dkvoorxt
    Snippet: The use of RNA interference (RNAi) is spreading rapidly to nearly every aspect of biomedical research. The gene silencing capability of RNAi is being used to study individual gene's biological function and role in biochemical pathways. However, the efficacy of RNAi depends upon efficient delivery of the intermediates of RNAi, short interfering RNA (siRNA) and short hairpin RNA (shRNA) oligonucleotides. The delivery challenge is even greater when the aim is to inhibit the expression of target gen
    Document: The use of RNA interference (RNAi) is spreading rapidly to nearly every aspect of biomedical research. The gene silencing capability of RNAi is being used to study individual gene's biological function and role in biochemical pathways. However, the efficacy of RNAi depends upon efficient delivery of the intermediates of RNAi, short interfering RNA (siRNA) and short hairpin RNA (shRNA) oligonucleotides. The delivery challenge is even greater when the aim is to inhibit the expression of target genes in animal models. Although i n vivo delivery of siRNA is complicated and challenging, recent results are encouraging. In this review, the latest developments of in vivo delivery of siRNA and the crucial issues related to this effort are addressed.

    Search related documents:
    Co phrase search for related documents
    • acute respiratory syndrome and administration method: 1, 2, 3, 4
    • acute respiratory syndrome and administration route: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and adrenergic receptor: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory syndrome and liver delivery: 1, 2, 3, 4
    • acute respiratory syndrome and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and liver metabolism: 1, 2, 3, 4, 5, 6
    • acute respiratory syndrome and liver target: 1, 2, 3, 4, 5, 6